MoonLake Immunotherapeutics (MLTX) is down -89.1%, or -$55.25 to $6.74.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLTX:
- Why Is MoonLake Immunotherapeutics Stock (MLTX) Down 90% Today?
- Video: Merus jumps after deal to be bought, MoonLake sinks after trial data
- Morning Movers: Tilray rises as Trump touts CBD benefits for seniors
- MoonLake Immunotherapeutics: Hold Rating Due to Unfavorable Phase 3 Results and Uncertain Market Prospects
- MoonLake Immunotherapeutics down 88% at $7.67 after Phase 3 HS data